|Articles|May 1, 2004
Phakic IOLs offer good outcomes to high myopes and hyperopes
The U.S. FDA study of the Implantable Collamer Lens (ICL, STAAR Surgical)used to treat high myopia (mean preoperative refraction, -10 D) and availablein four lengths (11.5 to 13 mm) shows good visual results in 526 eyes. Thesedata were presented at the American Society of Cataract and Refractive Surgery(ASCRS) annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
2
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
3
Study shows significant ocular changes following hemodialysis
4
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
5










































